HK1198124A1 - Dermal filler compositions for fine line treatment - Google Patents

Dermal filler compositions for fine line treatment Download PDF

Info

Publication number
HK1198124A1
HK1198124A1 HK14111615.6A HK14111615A HK1198124A1 HK 1198124 A1 HK1198124 A1 HK 1198124A1 HK 14111615 A HK14111615 A HK 14111615A HK 1198124 A1 HK1198124 A1 HK 1198124A1
Authority
HK
Hong Kong
Prior art keywords
dermal filler
filler compositions
fine line
line treatment
compositions
Prior art date
Application number
HK14111615.6A
Other languages
English (en)
Chinese (zh)
Inventor
Sumit Paliwal
Gabriel N. NJIKANG
Xiaojie Yu
Futian Liu
Nicholas J. Manesis
Original Assignee
Sumit Paliwal
Allergan Industrie, Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/052125 external-priority patent/WO2013028904A2/en
Application filed by Sumit Paliwal, Allergan Industrie, Sas filed Critical Sumit Paliwal
Publication of HK1198124A1 publication Critical patent/HK1198124A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/505—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK14111615.6A 2011-09-14 2012-09-13 Dermal filler compositions for fine line treatment HK1198124A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161534780P 2011-09-14 2011-09-14
US61/534,780 2011-09-14
USPCT/US2012/052125 2012-08-23
PCT/US2012/052125 WO2013028904A2 (en) 2011-08-25 2012-08-23 Dermal filler compositions including antioxidants
PCT/US2012/055211 WO2013040242A2 (en) 2011-09-14 2012-09-13 Dermal filler compositions for fine line treatment

Publications (1)

Publication Number Publication Date
HK1198124A1 true HK1198124A1 (en) 2015-03-13

Family

ID=47883970

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14111615.6A HK1198124A1 (en) 2011-09-14 2012-09-13 Dermal filler compositions for fine line treatment

Country Status (9)

Country Link
EP (1) EP2755630A2 (https=)
JP (4) JP6125509B2 (https=)
KR (4) KR20220013588A (https=)
CN (2) CN108379112A (https=)
AU (1) AU2012308503B2 (https=)
CA (1) CA2848833C (https=)
HK (1) HK1198124A1 (https=)
RU (1) RU2626513C2 (https=)
WO (1) WO2013040242A2 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
EP2484387A1 (en) 2011-02-03 2012-08-08 Q-Med AB Hyaluronic acid composition
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
KR102238406B1 (ko) 2011-06-03 2021-04-08 알러간 인더스트리 에스에이에스 항산화제를 포함하는 피부 충전제 조성물
CN108379112A (zh) * 2011-09-14 2018-08-10 阿勒根公司 用于细纹治疗的真皮填充剂组合物
KR20210071106A (ko) * 2011-12-08 2021-06-15 알러간 인더스트리 에스에이에스 진피 필러 조성물
US20140315828A1 (en) * 2013-04-22 2014-10-23 Allergan, Inc. Cross-linked silk-hyaluronic acid compositions
WO2014172784A1 (en) * 2013-04-25 2014-10-30 Aluron Biopharma Inc. Crosslinked hyaluronic acid compositions
WO2016128783A1 (en) * 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
HUE047971T2 (hu) 2015-02-13 2020-05-28 Allergan Ind Sas Az arcelemek - például az áll - formázására, megnagyobbítására vagy korrekciójára szolgáló implantátumok
US10988600B2 (en) * 2016-06-23 2021-04-27 Galderma Holding SA Cyclodextrin-grafted cross-linked hyaluronic acid complexed with active drug substances and uses thereof
EP3503841A4 (en) 2016-08-24 2020-04-22 Allergan, Inc. CO-CROSSLINKED HYALURONIC ACID-FIBROIN HYDROGELS FOR IMPROVING THE SUSTAINABILITY OF TISSUE GRAFTS AND FOR INCREASING SOFT TISSUES
EP4670750A3 (en) * 2017-06-12 2026-03-04 Advanced Aesthetic Technologies, Inc. Dermal filler
US20230190997A1 (en) 2017-06-26 2023-06-22 Evolved By Nature, Inc. Silk-hyaluronic acid based tissue filers and methods of using the same
AU2018290810C1 (en) * 2017-06-26 2024-09-12 Evolved By Nature, Inc. Silk-hyaluronic acid based tissue fillers and methods of using the same
CA3069968A1 (en) * 2017-07-19 2019-01-24 Dentsply Sirona Inc. Water-soluble hydrogel-based dental composition and methods of making and using same
CN111918640A (zh) * 2017-12-29 2020-11-10 马特克斯拉比有限公司 具有透明质酸基的填充物的制备方法
KR101967153B1 (ko) 2018-04-04 2019-04-09 윤성준 주름과 피부 결손 및 위축성 흉터 개선을 위한 필러 배합 조성물
WO2019238954A1 (en) * 2018-06-15 2019-12-19 Croma-Pharma Gmbh Hydrogel composition comprising a crosslinked polymer
EP3804769B1 (en) 2018-07-06 2025-05-21 Lg Chem, Ltd. Hyaluronic acid filler having high viscoelasticity and high cohesiveness
AU2019405953B2 (en) 2018-12-19 2025-09-18 Evolved By Nature, Inc. Silk-hyaluronic acid tissue fillers and methods of making and using the same
IT201900006929A1 (it) * 2019-05-16 2020-11-16 Giuliani Spa Kit per il trattamento estetico della pelle
CN110467689A (zh) * 2019-09-09 2019-11-19 山东众山生物科技有限公司 一种透明质酸衍生物及其制备方法
CN110907370A (zh) * 2019-12-04 2020-03-24 桂林理工大学 一种普适性的超灵敏化学与生物比色传感方法
US20230040919A1 (en) * 2019-12-26 2023-02-09 Allergan, Inc. Crosslinked ha-collagen hydrogels as dermal fillers
CN111249172A (zh) * 2020-01-15 2020-06-09 陈勇 一种美容注射凝胶及其制备方法
AR128245A1 (es) 2022-01-11 2024-04-10 Gpq S R L Nuevos derivados de ácido hialurónico como rellenos innovadores
WO2024055132A1 (es) * 2022-09-12 2024-03-21 Universidad De Talca Método para la síntesis de un copolímero ramificado de ácido hialurónico y ácido poli(láctico-co-glicólico)
KR102782287B1 (ko) 2022-12-19 2025-03-18 주식회사 코루파마 히알루론산과 아가 또는 아가로오스 복합화 하이드로겔 제조방법, 이로부터 제조된 히알루론산과 아가 또는 아가로오스를 포함하는 하이드로겔 및 이를 포함하는 필러 조성물
EP4450062A1 (en) * 2023-04-20 2024-10-23 Abiogen Pharma S.p.A. Composition for the treatment of osteoarthrosis

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174999B1 (en) * 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
KR100721752B1 (ko) * 2000-01-24 2007-05-25 쿠라레 메디카루 가부시키가이샤 수팽윤성 고분자 겔 및 그 제조법
IT1317091B1 (it) * 2000-02-08 2003-05-26 S F I R Societa Fondaria Ind R Gel di acido ialuronico cross-linked con l-amminoacidi ol-amminoesteri bifunzionali.
FR2811996B1 (fr) 2000-07-19 2003-08-08 Corneal Ind Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
WO2004067575A1 (en) * 2003-01-31 2004-08-12 Biosphere S.P.A. Water soluble and biocompatible gels of hyaluronic acid cross-linked with bi-functional l-aminoacids or l-aminoesters
AU2003206922A1 (en) 2003-02-19 2004-09-09 Aventis Pharmaceuticals Holdings Inc. Composition and method for intradermal soft tissue augmentation
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US8124120B2 (en) * 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
CA2550718C (en) * 2003-12-30 2013-11-05 Genzyme Corporation Cohesive gels from cross-linked hyaluronan and/or hylan, their preparation and use
FR2865737B1 (fr) * 2004-02-03 2006-03-31 Anteis Sa Gel reticule biocompatible
EP1750769B1 (en) * 2004-05-20 2013-01-23 Mentor Worldwide LLC Methods for making injectable polymer hydrogels
FR2873379B1 (fr) * 2004-07-23 2008-05-16 Jerome Asius Procede de preparation d'acide hyaluronique reticule, acide hyaluronique reticule susceptible d'etre obtenu par ledit procede, implant contenant ledit acide hyaluronique reticule, et son utilisation
FR2878444B1 (fr) 2004-11-30 2008-04-25 Corneal Ind Soc Par Actions Si Solutions viscoelastiques renfermant du hyaluronate de sodiu et de l'hydroxypropylmethylcellulose, preparation et utilisations
KR20080067619A (ko) * 2005-09-15 2008-07-21 유니버시티 오브 유타 리써치 파운데이션 고분자 조성물 및 이의 제조방법, 및 이의 용도
US20100273734A1 (en) * 2006-02-28 2010-10-28 Novozymes Biopolymer A/S Derivatives of Hyaluronic Acids
CN1837265A (zh) * 2006-04-25 2006-09-27 江南大学 一种透明质酸－羧甲基纤维素复合改性的方法
CN100417666C (zh) * 2006-09-07 2008-09-10 重庆大学 赖氨酸-壳聚糖树脂及其制备方法
FR2908415B1 (fr) * 2006-11-10 2009-01-23 Abr Dev Sarl Acide hyaluronique reticule et son procede de preparation
FR2909560B1 (fr) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
FR2918377B1 (fr) * 2007-07-05 2010-10-08 Estelle Piron Gel co-reticule de polysaccharides
US8394782B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
JP2011507841A (ja) * 2007-12-21 2011-03-10 エンセコール アーベー 活性物質を含む架橋したヒドロゲル
KR20090110090A (ko) * 2008-04-17 2009-10-21 엘지전자 주식회사 초음파를 이용한 인듐 셀레나이드 나노화합물의 제조방법및 이를 포함하는 화합물 반도체 태양전지
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
CN101961344A (zh) * 2009-07-23 2011-02-02 山东省生物药物研究院 药物组合物及其应用
IT1395392B1 (it) * 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
EP2504025A4 (en) * 2009-11-23 2013-05-01 Stephen F Olmstead COMPOSITIONS AND METHODS USING SERRATIA PEPTIDASE FOR INHIBITING AND TREATING BIOFILMS ASSOCIATED WITH PARTICULAR SUFFERING
US20110171286A1 (en) 2010-01-13 2011-07-14 Allergan, Inc. Hyaluronic acid compositions for dermatological use
US20110171311A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Stable hydrogel compositions including additives
US20110172180A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
KR102238406B1 (ko) * 2011-06-03 2021-04-08 알러간 인더스트리 에스에이에스 항산화제를 포함하는 피부 충전제 조성물
CN108379112A (zh) * 2011-09-14 2018-08-10 阿勒根公司 用于细纹治疗的真皮填充剂组合物

Also Published As

Publication number Publication date
EP2755630A2 (en) 2014-07-23
JP2017140433A (ja) 2017-08-17
AU2012308503A1 (en) 2014-04-03
CA2848833C (en) 2017-04-04
CA2848833A1 (en) 2013-03-21
JP6125509B2 (ja) 2017-05-10
RU2014113663A (ru) 2015-10-20
CN104105474B (zh) 2018-04-06
RU2626513C2 (ru) 2017-07-28
WO2013040242A3 (en) 2014-03-13
KR20140096028A (ko) 2014-08-04
KR102161861B1 (ko) 2020-10-26
KR20200116168A (ko) 2020-10-08
JP2014526342A (ja) 2014-10-06
AU2012308503B2 (en) 2015-08-13
KR20220013588A (ko) 2022-02-04
JP2019058692A (ja) 2019-04-18
CN104105474A (zh) 2014-10-15
WO2013040242A2 (en) 2013-03-21
JP2021100603A (ja) 2021-07-08
KR20210125119A (ko) 2021-10-15
CN108379112A (zh) 2018-08-10

Similar Documents

Publication Publication Date Title
HK1198124A1 (en) Dermal filler compositions for fine line treatment
JOP20180102A1 (ar) مركب صيدلاني
EP4578462A3 (en) Dermal filler compositions
WO2012167079A3 (en) Dermal filler compositions including antioxidants
EP3984556B8 (en) Polymeric treatment compositions
EP2681268B8 (en) Organosiloxane compositions
MX2012015188A (es) Composiciones de liberacion controlada con efecto de alimentos reducido.
EP3129494A4 (en) Hydrogel compositions for use in promoting tubulogenesis
PH12014501273A1 (en) Intranasal dexmedetomidine compositions and methods of use thereof
MX361862B (es) Composiciones y métodos que comprenden variante de enzima lipolítica.
PH12014500767A1 (en) Compositions for the treatment of dry eye
EP2672954A2 (en) Biotechnologically derived active in cosmetic compositions useful for protecting the skin from damages induced or produced by infrared-radiations
WO2013120022A3 (en) Treatment of hypoglycemia
EP4414376A3 (en) Novel depsipeptide and uses thereof
IN2014DN08299A (https=)
GEP201706739B (en) Compositions comprising vortioxetine and donepezil
MX359181B (es) Hidrolizado de colágeno y uso del mismo.
WO2012017321A3 (en) Treatment for dyslipidemia
EP2670888A2 (en) Aluminum treatment compositions
EP3076952A4 (en) Composition for oral delivery of bioactive agents
IN2014DN00254A (https=)
WO2014022475A3 (en) Compositions and methods for conformationally stabilizing primate immunodeficiency virus envelope glycoprotein trimers
MY165088A (en) Pharmaceutical compositions comprising alisporivir
EP2672952A1 (en) Hair treatment compositions
GB201003336D0 (en) Fungal treatment compositions